Literature DB >> 19944797

Pediatric inflammatory bowel disease: highlighting pediatric differences in IBD.

Cary G Sauer1, Subra Kugathasan.   

Abstract

Inflammatory bowel disease (IBD) includes Crohn disease and ulcerative colitis, and is often diagnosed in late childhood and early adulthood. What determines the age of onset remains unexplained. Early onset may represent the "pure" form of the disease process and hence may hold secrets of the initiating events of IBD pathogenesis. Clinical scientists continue to focus on pediatric IBD because it may shed light on the cause and prevention of this lifelong disease. Over the last decade, data in pediatric IBD studies have demonstrated many similarities and differences between pediatric and adult onset, which continue to add pieces to an increasingly complex IBD puzzle. The mechanism responsible for these similarities and differences remains unanswered. This article discusses clinically relevant epidemiology and treatment aspects of pediatric IBD, with special focus on similarities and differences in pediatric and adult IBD. Evidence-based treatment algorithms, with special focus on pediatric studies and care for children, are also highlighted.

Entities:  

Year:  2010        PMID: 19944797     DOI: 10.1016/j.mcna.2009.10.002

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  13 in total

Review 1.  Orphan drug development: the increasing role of clinical pharmacology.

Authors:  Mariam A Ahmed; Malek Okour; Richard Brundage; Reena V Kartha
Journal:  J Pharmacokinet Pharmacodyn       Date:  2019-07-23       Impact factor: 2.745

2.  A questionnaire survey of pediatric inflammatory bowel disease in India.

Authors:  Malathi Sathiyasekaran; Sumathi Bavanandam; Srinivas Sankaranarayanan; Neelam Mohan; M Geetha; Nishanth Wadhwa; Mohit Kehar; Vishnu Biradar
Journal:  Indian J Gastroenterol       Date:  2015-01-16

3.  Market share and costs of biologic therapies for inflammatory bowel disease in the USA.

Authors:  H Yu; D MacIsaac; J J Wong; Z M Sellers; A A Wren; R Bensen; C Kin; K T Park
Journal:  Aliment Pharmacol Ther       Date:  2017-11-22       Impact factor: 8.171

4.  Inflammatory Bowel Disease Across the Age Continuum: Similarity and Disparity.

Authors:  Amey Dilip Sonavane; Pratibha Sonawane; Deepak N Amarapurkar
Journal:  Indian J Pediatr       Date:  2018-03-23       Impact factor: 1.967

Review 5.  Inflammatory Bowel Disease in Childhood and Adolescence.

Authors:  Jan Däbritz; Patrick Gerner; Axel Enninger; Martin Claßen; Michael Radke
Journal:  Dtsch Arztebl Int       Date:  2017-05-12       Impact factor: 5.594

6.  Comparative genetic analysis of inflammatory bowel disease and type 1 diabetes implicates multiple loci with opposite effects.

Authors:  Kai Wang; Robert Baldassano; Haitao Zhang; Hui-Qi Qu; Marcin Imielinski; Subra Kugathasan; Vito Annese; Marla Dubinsky; Jerome I Rotter; Richard K Russell; Jonathan P Bradfield; Patrick M A Sleiman; Joseph T Glessner; Thomas Walters; Cuiping Hou; Cecilia Kim; Edward C Frackelton; Maria Garris; James Doran; Claudio Romano; Carlo Catassi; Johan Van Limbergen; Stephen L Guthery; Lee Denson; David Piccoli; Mark S Silverberg; Charles A Stanley; Dimitri Monos; David C Wilson; Anne Griffiths; Struan F A Grant; Jack Satsangi; Constantin Polychronakos; Hakon Hakonarson
Journal:  Hum Mol Genet       Date:  2010-02-22       Impact factor: 6.150

7.  Cosmc is an X-linked inflammatory bowel disease risk gene that spatially regulates gut microbiota and contributes to sex-specific risk.

Authors:  Matthew R Kudelka; Benjamin H Hinrichs; Trevor Darby; Carlos S Moreno; Hikaru Nishio; Christopher E Cutler; Jianmei Wang; Huixia Wu; Junwei Zeng; Yingchun Wang; Tongzhong Ju; Sean R Stowell; Asma Nusrat; Rheinallt M Jones; Andrew S Neish; Richard D Cummings
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-07       Impact factor: 11.205

8.  Mild clinical behaviour of Crohn disease in elderly patients in a Latin American country: A case-control study.

Authors:  Jesús K Yamamoto-Furusho; Andrea Sarmiento-Aguilar
Journal:  Can J Gastroenterol Hepatol       Date:  2015-05-21

9.  Long-term Efficacy and Safety of Adalimumab in Pediatric Patients with Crohn's Disease.

Authors:  William A Faubion; Marla Dubinsky; Frank M Ruemmele; Johanna Escher; Joel Rosh; Jeffrey S Hyams; Samantha Eichner; Yao Li; Nattanan Reilly; Roopal B Thakkar; Anne M Robinson; Andreas Lazar
Journal:  Inflamm Bowel Dis       Date:  2017-03       Impact factor: 5.325

10.  Clinical course and outcomes of diagnosing Inflammatory Bowel Disease in children 10 years and under: retrospective cohort study from two tertiary centres in the United Kingdom and in Italy.

Authors:  Marco Gasparetto; Graziella Guariso; Laura Visona' Dalla Pozza; Alexander Ross; Robert Heuschkel; Matthias Zilbauer
Journal:  BMC Gastroenterol       Date:  2016-03-15       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.